γ-Secretase Modulation in Alzheimer's Disease Pathophysiology

γ-Secretase is a multi‐subunit intramembrane protease complex responsible for the final cleavage of the amyloid precursor protein (APP), yielding amyloid-β (Aβ) peptides of varying lengths. The relative abundance of longer, aggregation-prone species such as Aβ42 and Aβ43 is strongly implicated in the onset and progression of Alzheimer's disease. Modulation of γ-secretase activity aims to attenuate the production of these pathogenic peptides while preserving essential processing of other substrates, notably those involved in cell signalling. Recent advances in structural biology and biophysics have clarified how subunits such as presenilin and APH-1 influence substrate recognition and catalysis, and how small-molecule modulators alter cleavage specificity through allosteric binding sites. At the same time, the broader role of γ-secretase in lipid homeostasis, synaptic function and glial response underscores its position as a central integrator of neuronal health and inflammatory signalling. Understanding the balance between therapeutic efficacy and off-target effects remains key to translating γ-secretase modulation into safe and effective interventions for Alzheimer’s disease.

Research from Nature Portfolio

High-resolution cryo-electron microscopy of the human γ-secretase complex in both its apo form and bound to an intermediate Aβ46 substrate has revealed the structural basis for substrate recognition and processive catalysis. This work identifies three divergent regions in the APH-1 subunit that interface with presenilin and undergo conformational rearrangements upon substrate engagement. Detailed mapping of hydrogen-bond networks between Aβ46 and loop regions of presenilin elucidates critical contacts required for sequential trimming of the peptide. These insights establish a mechanistic framework for the design of allosteric modulators that can fine-tune γ-secretase activity, shifting the cleavage profile away from longer, pathogenic Aβ species without complete inhibition of protease function.

γ-Secretase Modulation in Alzheimer's Disease Pathophysiology publication trend

The graph below shows the total number of articles in γ-secretase modulation in alzheimer's disease pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

γ-Secretase: A multi‐subunit aspartyl protease complex that mediates intramembrane cleavage of APP and numerous other type-I membrane proteins.

Amyloid precursor protein (APP): A transmembrane protein cleaved by β-secretase and γ-secretase to generate amyloid-β peptides.

Amyloid-β (Aβ): Peptide fragments of APP that can aggregate into oligomers and plaques, central to Alzheimer’s pathogenesis.

Presenilin: The catalytic subunit of γ-secretase, harbouring the active-site aspartate residues essential for peptide bond hydrolysis.

γ-Secretase modulator (GSM): Small molecules that bind allosteric sites on γ-secretase to shift its cleavage preference towards shorter, less pathogenic Aβ species without full inhibition.

References

1. Apo and Aβ46-bound γ-secretase structures provide insights into amyloid-β processing by the APH-1B isoform. Nature Communications (2024).
2. GS-SMD server for steered molecular dynamics of peptide substrates in the active site of the γ-secretase complex.. Nucleic Acids Research (2023).
3. Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer’s disease. Neuron (2023).
4. The γ-secretase substrate proteome and its role in cell signaling regulation. Molecular Cell (2023).